Purdue Pharma

Photo
31.05.2023 • News

Bankrupt Purdue Pharma Cleared to Sell Consumer Unit

Privately held US drugmaker Purdue Pharma has received permission from a US bankruptcy court to sell its consumer health business, Avrio Health, for $397 million to a subsidiary of Arcadia Consumer Healthcare.

Photo
28.02.2022 • News

J&J and Distributors Finalize Opioid Settlements

US healthcare giant Johnson & Johnson and three major distributors, AmerisourceBergen, Cardinal Health and McKesson, have finalized a long-negotiated nationwide settlement linked to their responsibility for the opioid addiction crisis.

Photo
08.09.2021 • News

Opioids Deal Dissolves Purdue Pharma

At the end of a long-running controversial case, US drugmaker Purdue Pharma, manufacturer of the opioid painkiller OxyContin, has won court approval for a multibillion-dollar restructuring plan it helped to engineer that will shelter the company and its principal owners, the Sackler family, from lawsuits.

Photo
26.10.2020 • News

Purdue Settles with US Justice Department

OxyContin maker Purdue Pharma has agreed to plead guilty to three criminal charges in federal court in New Jersey for its part in fueling an opioid crisis in the US. The company, which filed for bankruptcy in 2019, paid doctors to write more opioid prescriptions “without a legitimate medical purpose.”

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.